The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011–20
Abstract
An analysis of return on investment can help policy makers support, optimize, and advocate for the expansion of immunization programs in the world's poorest countries. We assessed the return on investment associated with achieving projected coverage levels for vaccinations to prevent diseases related to ten antigens in ninety-four low- and middle-income countries during 2011-20, the Decade of Vaccines. We derived these estimates by using costs of vaccines, supply chains, and service delivery and their associated economic benefits. Based on the costs of illnesses averted, we estimated that projected immunizations will yield a net return about 16 times greater than costs over the decade (uncertainty range: 10-25). Using a full-income approach, which quantifies the value that people place on living longer and healthier lives, we found that net returns amounted to 44 times the costs (uncertainty range: 27-67). Across all antigens, net returns were greater than costs. But to realize the substantial positive return on investment from immunization programs, it is essential that governments and donors provide the requisite investments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The value of a statistical life: A critical review of market estimates throughout the world
Viscusi, W. K., & Aldy, J. E. (2003) · Journal of Risk and Uncertainty · doi:10.1023/a:1025598106257 · Cited by 2,135
Global Illness and Deaths Caused by Rotavirus Disease in Children
Parashar, U. D., Hummelman, E. G., Bresee, J. S., Miller, M. A., & Glass, R. I. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0905.020562 · Cited by 1,898
Global health 2035: a world converging within a generation
Jamison, D. T., Summers, L. H., Alleyne, G., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., Evans, D., Feachem, R. G. A., Frenk, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62105-4 · Cited by 1,220
[Global health 2035: a world converging within a generation].
Jamison, D. T. T., Summers, L. H., Alleyne, G. A. O., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., EVANS, D. B., Feachem, R. G., Frenk, J. M., et al. (2015) · PubMed · Cited by 943
Global estimate of the incidence of clinical pneumonia among children under five years of age.
Rudan, I., Tomašković, L., Boschi-Pinto, C., & Campbell, H. J. (2004) · Europe PMC (PubMed Central) · Cited by 497
Stenberg, K., Axelson, H., Sheehan, P., Anderson, I., Gülmezoglu, A. M., Temmerman, M., Mason, E., Friedman, H. S., Bhutta, Z. A., Lawn, J. E., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62231-x · Cited by 355
Ozawa, S., Mirelman, A., Stack, M. L., Walker, D. G., & Levine, O. S. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.103 · Cited by 254
Self-citationBloom, D. E., Canning, D., & Weston, M. (2017) · Fighting the Diseases of Poverty · doi:10.4324/9780203791950-8 · Cited by 238
Lee, L. A., Franzel, L., Atwell, J., Datta, S. D., Friberg, I. K., Goldie, S. J., Reef, S. E., Schwalbe, N., Simons, E., Strebel, P. M., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.11.035 · Cited by 181
Self-citationSingle versus multi-dose vaccine vials: An economic computational model
Lee, B. Y., Norman, B. A., Assi, T.-M., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.05.048 · Cited by 107
Cited by
Impact of Vaccines; Health, Economic and Social Perspectives
Rodrigues, C. M. C., & Plotkin, S. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01526 · Cited by 737
Simply put: Vaccination saves lives
Orenstein, W. A., & Ahmed, R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704507114 · Cited by 446
Novel approaches for vaccine development
Gebre, M. S., Brito, L. A., Tostanoski, L. H., Edwards, D. K., Carfi, A., & Barouch, D. H. (2021) · Cell · doi:10.1016/j.cell.2021.02.030 · Cited by 347
Li, X., Mukandavire, C., Cucunubá, Z. M., Echeverria Londono, S., Abbas, K., Clapham, H. E., Jit, M., Johnson, H. L., Papadopoulos, T., Vynnycky, E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32657-x · Cited by 300
Immunization: vital progress, unfinished agenda
Piot, P., Larson, H. J., O’Brien, K. L., N’kengasong, J., Ng, E., Sow, S., & Kampmann, B. (2019) · Nature · doi:10.1038/s41586-019-1656-7 · Cited by 206
The world of immunization: achievements, challenges, and strategic vision for the next decade
Lindstrand, A., Cherian, T., Chang-Blanc, D., Feikin, D., & O’Brien, K. L. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab284 · Cited by 179
Nandi, A., & Shet, A. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1708669 · Cited by 176
Sim, S. Y., Watts, E., Constenla, D., Brenzel, L., & Patenaude, B. N. (2020) · Health Affairs · doi:10.1377/hlthaff.2020.00103 · Cited by 143
Self-citationHaeuser, E., Byrne, S., Nguyen, J., Raggi, C., McLaughlin, S. A., Bisignano, C., Harris, A. A., Smith, A. E., Lindstedt, P. A., Smith, G., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01037-2 · Cited by 143
Addressing the persistent inequities in immunization coverage
Chopra, M., Bhutta, Z., Chang Blanc, D., Checchi, F., Gupta, A., Lemango, E. T., Levine, O. S., Lyimo, D., Nandy, R., O'Brien, K. L., et al. (2020) · Bulletin of the World Health Organization · doi:10.2471/blt.19.241620 · Cited by 90
Transforming cold chain performance and management in lower-income countries
Brison, M., & LeTallec, Y. (2017) · Vaccine · doi:10.1016/j.vaccine.2016.11.067 · Cited by 44
Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
Mumtaz, H., Nadeem, A., Bilal, W., Ansar, F., Saleem, S., Khan, Q. A., Tango, T., Farkouh, C., Belay, N. F., Verma, R., et al. (2023) · Immunity, Inflammation and Disease · doi:10.1002/iid3.899 · Cited by 42
Metadata
- Authors
- Ozawa, S., Clark, S., Portnoy, A., Grewal, S., Brenzel, L., & Walker, D. G.
- Venue
- Health Affairs
- Publisher
- Health Affairs Publishing, LLC
- Published
- 2016-02
- Volume
- 35
- Issue
- 2
- Pages
- 199-207
- ISSN
- 0278-2715 (ISSN-L)
- 1544-5208
- OpenAlex
- W2267348261
- Cited by
- 371
- References
- 20
- FWCI
- 61.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.